Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma
Alexander Scholz, Patrick N. Harter, Sebastian Cremer, Burak H. Yalcin, Stefanie Gurnik, Maiko Yamaji, Mariangela Di Tacchio, Kathleen Sommer, Peter Baumgarten, Oliver Bähr, Joachim P. Steinbach, Jörg Trojan, Martin Glas, Ulrich Herrlinger, Dietmar Krex, Matthias Meinhardt, Astrid Weyerbrock, Marco Timmer, Roland Goldbrunner, Martina DeckertChristian Braun, Jens Schittenhelm, Jochen T. Frueh, Evelyn Ullrich, Michel Mittelbronn, Karl H. Plate, Yvonne Reiss*
*Corresponding author for this work
Research output: Contribution to journal › Article › Research › peer-review
120Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma'. Together they form a unique fingerprint.